The Beginners’ Portfolio Buys Aviva plc

Aviva plc (LON: AV) takes the final slot on our portfolio, as we pass on RSA Insurance Group plc (LON: RSA).

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

This article is the latest in a series that aims to help novice investors with the stock market. To enjoy past articles in the series, please visit our full archive.

The Beginners’ Portfolio is a virtual portfolio, with all costs, spreads and dividends accounted for. Transactions are for educational purposes only and do not constitute advice to buy or sell.

It’s taken a while, but I’ve finally decided on the last of the ten shares to take their exalted place in the Fool’s Beginners’ Portfolio. After deciding that an insurer could offer us good prospects while adding a bit of diversity, the choice was between RSA Insurance Group (LSE: RSA) and Aviva (LSE: AV), both of which have slashed their dividends recently and have seen their share prices falling.

The choice is Aviva, and we got 151 shares at a price at 321.4p, which commission and stamp duty took to a total cost of £497.71.

Here’s what the final purchase tally looks like, with all 10 portfolio places filled:

Company Buy price Share cost Charges Total cost
Vodafone 168.5p £487.07 £12.44 £499.51
Tesco 305.5p £485.80 £12.43 £498.23
GlaxoSmithKline 1,440.5p £489.77 £12.45 £502.22
Persimmon 617.9p £488.11 £12.44 £500.55
Blinkx
36.9p £487.24 £12.44 £499.68
BP
434.5p £486.58 £12.43 £499.01
Rio Tinto 3,048.4p £487.74 £12.44 £500.18
BAE Systems 332.3p £485.16 £12.43 £497.59
Apple $458.40 £588.48 £17.50 £605.98
Aviva 321.4p £458.28 £12.43 £497.71
Total   £4,944.23 £129.43 £5,100.66

We’ve invested £100 more than our original target of £5,000, simply because that’s what it took to get hold of two Apple shares. I could have reduced the investment in Aviva to compensate, but I really didn’t want to drop the final slice as low as £400.

Why Aviva?

Here are some of the valuation fundamentals of our two insurance candidates:

Company Price Historic
EPS
Historic
dividend
Forecast
EPS
Forecast
dividend
Forward
P/E
RSA 116p 9.5p 5.8% 12.5p 6.3% 9.3
Aviva 321p -15.2p 5.1% 45.7p 6.6% 7.0

On these figures, both look cheap to me, but I think Aviva shareholders have been more shaken by the dividend cut and the shares have been oversold a little more fiercely. But really, I think I’d be happy to hold either of these companies (and I have owned RSA shares in the past, myself).

So the portfolio is now full, and I won’t be investing in any new companies unless I choose to sell one of the existing holdings. And I’ll only do that if I believe a share has become overvalued or there’s a significantly better place for the money. Knowing when to sell is my weakest point, so that will be a challenge for me.

Valuation update

I’ll do a valuation update in due course, but I think a quick mention of Vodafone (LSE: VOD) is in order. As I wrote recently, I believe Vodafone is one of those great long-term investments that’s ideal for an ISA.

Though it’s still early days, Vodafone has already done well for the portfolio. Since I kicked off the portfolio by buying the shares at 168.5p apiece in May 2012, we’re up 11.7% (excluding dividends) based on the current bid price of 188.3p.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has recommended Apple, GlaxoSmithKline, and Vodafone. The Motley Fool UK owns shares of Apple and Tesco. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »